Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study33

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study17

Views

Views
September 20242
October 20243
November 20240
December 20240
January 20250
February 20250
March 202512
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore11
United States5
Germany1
 

Top cities views

Views
Chicago1
Fort Worth1
Nuremberg1